参考文献
［1］Cerrito L，Annicchiarico B E，Iezzi R，et al.Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus［J］.World J Gastroenterol，2010，17（8）：2073-2080.
［2］Chen W Q，Zheng R S，Baade P D，et al.Cancer statistics in China，2015［J］.CA Cancer J Clin，2016，66（2）：115-132.
［3］Chen Z H，Zhang X P，Wang K，et al.Liver resection versus transcatheter arterial chemoembolization for the treatment of patients with hepatocellular carcinoma and hepatic vein or inferior vena cava tumor thrombus：a propensity score matching analysis［J］.Hepatol Res，2019，49（4）：441-452.
［4］Chen Z H，Wang K，Zhang X P，et al.A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus［J］.HepatoBiliary Surg Nutr，2020，9（6）：717-728.
［5］Gao J，Zhang Q，Zhang J，et al.Radiofrequency ablation of the main lesion of hepatocellular carcinoma and bile duct tumor thrombus as a radical therapeutic alternative：two case reports［J］.Medicine（Baltimore），2015，94（27）：e1122.
［6］Ikenaga N，Chijiiwa K，Otani K，et al.Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion［J］.J Gastrointest Surg，2009，13（3）：492-497.
［7］Jm K，Ch K，Jw J，et al.Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy：a matched study［J］.Medicine（Baltimore），2015，94（6）：e450.
［8］Kim D S，Kim B W，Hatano E，et al.Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus：a Korea-Japan multicenter study［J］.Ann Surg，2020，271（5）：913-921.
［9］Kokudo T，Hasegawa K，Matsuyama Y，et al.Liver resection for hepatocellular carcinoma associated with hepatic vein invasion：a Japanese nationwide survey［J］.Hepatology，2017，66（2）：510-517.
［10］Kokudo T，Hasegawa K，Matsuyama Y，et al.Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion［J］.J Hepatol，2016，65（5）：938-943.
［11］Kokudo T，Hasegawa K，Yamamoto S，et al.Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis［J］.J Hepatol，2014，61（3）：583-588.
［12］Kudo M，Kitano M，Sakurai T，et al.General rules for the clinical and pathological study of primary liver cancer，nationwide follow-up survey and clinical practice guidelines：the outstanding achievements of the Liver Cancer Study Group of Japan［J］.Dig Dis，2015，33（6）：765-770.
［13］Liu Q Y，Lin X F，Li H G，et al.Tumors with macroscopic bile duct thrombi in non-HCC patients：dynamic multi-phase MSCT findings［J］.World J Gastroenterol，2012，18（11）：1273-1278.
［14］Llovet H M，Burroughs A，Bruix J.Hepatocellular carcinoma［J］.Lancet，2003，362（9399）：1907-1917.
［15］Llovet J M，Ricci S，Mazzaferro V，et al.Sorafenib in advanced hepatocellular carcinoma［J］.N Engl J Med，2008，359（4）：378-390.
［16］Moon D B，Hwang S，Wang H J，et al.Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus：a Korean multicenter study［J］.World J Surg，2013，37（2）：443-451.
［17］Narita R，Oto T，Mimura Y，et al.Biliary obstruction caused by intrabiliary transplantation from hepatocellular carcinoma［J］.J Gastroenterol，2002，37（1）：55-58.
［18］Navadgi S，Chang C C，Bartlett A，et al.Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma（HCC）with and without bile duct thrombus［J］.HPB（Oxford），2016，18（4）：312-316.(https://www.daowen.com)
［19］Noda T，Nagano H，Tomimaru Y，et al.Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery［J］.Surgery，2011，149（3）：371-377.
［20］Oba A，Takahashi S，Kato Y，et al.Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus［J］.Anticancer Res，2014，34（8）：4367-4372.
［21］Qin L X，Ma Z C，Wu Z Q，et al.Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct：experience of 34 patients［J］.World J Gastroenterol，2004，10（10）：1397-1401.
［22］Satoh S，Ikai I，Honda G，et al.Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi［J］.Surgery，2000，128（5）：779-783.
［23］Shen Y Y，Li P，Cui K，et al.Neoadjuvant transcatheter arterial chemoembolization for biliary tumor thombosis：a retrospective study［J］.Int J Technol Assess Health Care，2016，32（4）：212-217.
［24］Shi J，Lai Eric C H，Li N，et al.A new classification for hepatocellular carcinoma with portal vein tumor thrombus［J］.J Hepatobiliary Pancreat Sci，2011，18（1）：74-80.
［25］Shibata T，Yamamoto N，Ikai I，et al.Choledochojejunostomy：possible risk factor for septic complications after percutaneous hepatic tumor ablation［J］.AJR Am J Roentgenol，2000，174（4）：985-986.
［26］Shiomi M，Kamiya J，Nagino M，et al.Hepatocellular carcinoma with biliary tumor thrombi：aggressive operative approach after appropriate preoperative management［J］.Surgery，2001，129（6）：692-698.
［27］Sun J，Yang L，Shi J，et al.Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus：an open-label randomized controlled trial［J］.Radiother Oncol，2019，140：20-25.
［28］Ueda M，Takeuchi T，Takayasu T，et al.Classification and surgical treatment of hepatocellular carcinoma（HCC）with bile duct thrombi［J］.Hepatogastroenterology，1994，41（4）：349-354.
［29］Wei X B，Jiang Y B，Zhang X P，et al.Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus：a randomized，open-label，multicenter controlled study［J］.J Clin Oncol，2019，37（24）：2141-2151.
［30］Xp Z，Yz G，Zh C，et al.An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus：amulticenter study［J］.Hepatology，2019，69（5）：2076-2090.
［31］Yamamoto S，Hasegawa K，Inoue Y，et al.Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus［J］.Ann Surg，2015，261（5）：e123-125.
［32］Yang M J，Fang Z T，Yan Z P，et al.Transarterial chemoembolisation（TACE）combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone：a two-arm，randomised clinical trial［J］.J Cancer Res Clin Oncol，2014，140（2）：211-219.
［33］Yang X，Qiu Z，Ran R，et al.Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis［J］.Oncol Lett，2018，16（3）：3593-3602.
［34］Yu X H，Xu L B，Liu C，et al.Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi［J］.Dig Dis Sci，2011，56（1）：252-259.
［35］Zeng H，Xu L B，Wen J M，et al.Hepatocellular carcinoma with bile duct tumor thrombus：a clinicopathological analysis of factors predictive of recurrence and outcome after surgery［J］.Medicine（Baltimore），2015，94（1）：e364.
［36］Zhang X P，Chen Z H，Zhou T F，et al.A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection：a large-scale，multicenter study［J］.Eur J Surg Oncol，2019，45（9）：1644-1651.